Search

Author/Creator Shuster, Dale

1. Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor. (14th October 2021)

Authors:
Yin, Ophelia; Zahir, Hamim; French, Jonathan; Polhamus, Daniel; Wang, Xiaoning; van de Sande, Michiel; Tap, William D.; Gelderblom, Hans; Wagner, Andrew J.; Healey, John H.; Greenberg, Jonathan; Shuster, Dale; Stacchiotti, Silvia
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 10:Number 11(2021)
Page Start:
1422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial. (4th July 2021)

Authors:
Van De Sande, Michiel; Tap, William D; Gelhorn, Heather L; Ye, Xin; Speck, Rebecca M; Palmerini, Emanuela; Stacchiotti, Silvia; Desai, Jayesh; Wagner, Andrew J; Alcindor, Thierry; Ganjoo, Kristen; Martín-Broto, Javier; Wang, Qiang; Shuster, Dale; Gelderblom, Hans; Healey, John H
Journal:
Acta orthopaedica
Issue:
Volume 92:Number 4(2021)
Page Start:
493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN. Issue 1 (24th January 2023)

Authors:
Healey, John H.; Tap, William D.; Gelhorn, Heather L.; Ye, Xin; Speck, Rebecca M.; Palmerini, Emanuela; Stacchiotti, Silvia; Desai, Jayesh; Wagner, Andrew J.; Alcindor, Thierry; Ganjoo, Kristen; Martín-Broto, Javier; Wang, Qiang; Shuster, Dale; Gelderblom, Hans; van de Sande, Michiel
Journal:
Clinical orthopaedics and related research
Issue:
Volume 481:Issue 1(2023)
Page Start:
107
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors. (11th October 2020)

Authors:
Yin, Ophelia; Wagner, Andrew J.; Kang, Jia; Knebel, William; Zahir, Hamim; van de Sande, Michiel; Tap, William D.; Gelderblom, Hans; Healey, John H.; Shuster, Dale; Stacchiotti, Silvia
Journal:
Journal of clinical pharmacology
Issue:
Volume 61:Number 4(2021)
Page Start:
480
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study. Issue 5 (May 2018)

Authors:
Rimassa, Lorenza; Assenat, Eric; Peck-Radosavljevic, Markus; Pracht, Marc; Zagonel, Vittorina; Mathurin, Philippe; Rota Caremoli, Elena; Porta, Camillo; Daniele, Bruno; Bolondi, Luigi; Mazzaferro, Vincenzo; Harris, William; Damjanov, Nevena; Pastorelli, Davide; Reig, María; Knox, Jennifer; Negri,...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 5(2018)
Page Start:
682
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗